Polatuzumab Vedotin: Current Role and Future Applications in the Treatment of Patients with Diffuse Large B-Cell Lymphoma

Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous disease. Despite good responses to standard of care frontline chemoimmunotherapy, the prognosis of relapsed/refractory (R/R) patients remains obscured by the possible inadequate responses to salvage therapy, eligibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Assi, Rita, Masri, Nohad, Dalle, Iman Abou, El-Cheikh, Jean, Ghanem, Hady, Bazarbachi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432323/
https://www.ncbi.nlm.nih.gov/pubmed/34595463
http://dx.doi.org/10.2991/chi.k.210305.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432323/
https://www.ncbi.nlm.nih.gov/pubmed/34595463
http://dx.doi.org/10.2991/chi.k.210305.001

Ejemplares similares